Cite
Viflpocetine inhibits NF-κB–dependent inflammation via an IKK-dependent but PDE-independent mechanism.
MLA
Kye-Im Jeon, et al. “Viflpocetine Inhibits NF-ΚB–dependent Inflammation via an IKK-Dependent but PDE-Independent Mechanism.” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 21, May 2010, pp. 9795–800. EBSCOhost, https://doi.org/10.1073/pnas.0914414107.
APA
Kye-Im Jeon, Xiangbin Xu, Aizawa, T., Jae Hyang Lim, Hirofumi Jono, Dong-Seok Kwon, Jun-ichi Abe, Berk, B. C., Jian-Dong Li, & Chen Yan. (2010). Viflpocetine inhibits NF-κB–dependent inflammation via an IKK-dependent but PDE-independent mechanism. Proceedings of the National Academy of Sciences of the United States of America, 107(21), 9795–9800. https://doi.org/10.1073/pnas.0914414107
Chicago
Kye-Im Jeon, Xiangbin Xu, Toru Aizawa, Jae Hyang Lim, Hirofumi Jono, Dong-Seok Kwon, Jun-ichi Abe, Bradford C. Berk, Jian-Dong Li, and Chen Yan. 2010. “Viflpocetine Inhibits NF-ΚB–dependent Inflammation via an IKK-Dependent but PDE-Independent Mechanism.” Proceedings of the National Academy of Sciences of the United States of America 107 (21): 9795–9800. doi:10.1073/pnas.0914414107.